ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Family Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

11,205Medicare Part D Prescriptions Filled, Including Refills

Rank: 194 out of 676

$420K Total Retail Price of All Prescriptions

Rank: 266 out of 676

568 Patients Receiving at Least One Drug in Part D
52%Patients 65 Years and Older
67% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Mississippi
Lower avg

Schedule Two
Controlled Substances

2% of this provider’s 568 patients filled at least one prescription for a schedule two drug, compared to an average of 3%.

Schedule Three
Controlled Substances

16% of this provider’s 568 patients filled at least one prescription for a schedule three drug, compared to an average of 19%.

Risky Drugs to Seniors

3% of this provider’s 7,130 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 2%.

Brand Name Drugs

22% of this provider’s prescriptions were for brand-name drugs, compared to an average of 24%.

Prescription Price

$38 was the average price of a prescription from this provider, compared to $50 among peers.

Prescriptions per Patient

20 is the average number of prescriptions (including refills) per patient, compared to an average of 22.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Mississippi
AMLODIPINE BESYLATE 568 436 1 3
LEVOTHYROXINE SODIUM 473 297 2 7
LISINOPRIL 466 322 3 5
FUROSEMIDE 415 282 4 4
METFORMIN HCL 394 265 5 8
OMEPRAZOLE 349 234 6 2
POTASSIUM CHLORIDE 347 230 7 9
ZOLPIDEM TARTRATE 254 178 8 21
TRIAMTERENE-HCTZ 240 167 9 43
LOVASTATIN 181 136 10 33
LOSARTAN POTASSIUM 173 154 11 34
CARVEDILOL 165 108 12 15
ATENOLOL 164 136 13 25
AMLODIPINE BESYLATE-BENAZEPRIL 157 120 14 44
TRAMADOL HCL 155 72 15 19
RANITIDINE HCL 148 82 16 27
PRAVASTATIN SODIUM 147 96 17 11
SIMVASTATIN 146 88 18 6
HYDROCODONE-ACETAMINOPHEN 143 64 S3 19 1
DIOVAN 143 116 19 37
GLIMEPIRIDE 130 94 21 30
HYDROCHLOROTHIAZIDE 125 94 22 12
GABAPENTIN 110 70 23 10
CLONIDINE HCL 109 86 24 32
ATORVASTATIN CALCIUM 107 65 25 20
LISINOPRIL-HYDROCHLOROTHIAZIDE 106 39 26 16
CYCLOBENZAPRINE HCL 105 34 R 27 50
CITALOPRAM HBR 97 57 28 17
SERTRALINE HCL 92 59 29 26
METOPROLOL SUCCINATE 86 62 30 14
CEPHALEXIN 84 28 31 84
AMITRIPTYLINE HCL 76 48 R 32 46
WARFARIN SODIUM 75 51 33 18
KLOR-CON M20 75 49 33 67
FAMOTIDINE 71 50 35 64
PHENYTOIN SODIUM EXTENDED 68 31 36 88
LEVOFLOXACIN 68 44 36 91
CRESTOR 68 44 36 29
LOSARTAN-HYDROCHLOROTHIAZIDE 68 53 36 51
VENLAFAXINE HCL ER 67 13 40 98
CARISOPRODOL 66 0 R 41 60
NEXIUM 65 24 42 23
HYDROXYZINE HCL 59 35 R 43 225
PAROXETINE HCL 58 31 44 65
SYNTHROID 58 32 44 48
BENAZEPRIL HCL 55 36 46 58
HYDRALAZINE HCL 55 40 46 77
CLOPIDOGREL 54 50 48 28
FLUCONAZOLE 53 27 49 115
TAMSULOSIN HCL 52 45 50 38
PLAVIX 52 51 50 40
LYRICA 52 22 50 57
FENOFIBRATE 52 37 50 90
DILTIAZEM ER 51 34 54 118
METOPROLOL TARTRATE 50 34 55 22
GLIPIZIDE 50 50 55 81
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on March 4, 2011.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.